Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
31
1
3
4
5
6
7
12:00 AM - Heart Ailments
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
25
26
27
28
29
30
1
2
3
Diabetes, Obesity and Its Complications
2021-09-02 - 2021-09-03    
All Day
Diabetes Congress 2021 aims to provide a platform to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial [...]
Heart Ailments
2021-09-07 - 2021-09-08    
All Day
International conference and Expo on Heart Ailments Webinar held at Zoom or WebEx online on September 07-08, 2021. The conference is concentrated on the theme [...]
Computer Graphics & Animation 2021
2021-09-24 - 2021-09-25    
All Day
Computer graphics is branch of Computer Science and Technology It’s a graphical pattern of an image or objects which created by using specific software and [...]
Events on 2021-09-02
Events on 2021-09-07
Heart Ailments
7 Sep 21
Events on 2021-09-24
Articles

Jun 02 : EMR: A Balancing Act of Patient Safety, Privacy & Health Care Delivery

somerset medical center

With almost $35 billion appropriated in government incentives and additional funds spent in development by institutions, the concept of an electronic patient record (EPR) within integrated health information technology (HIT) systems has taken the United States by storm. However, the United Kingdom’s expensive struggle to implement a seamless EPR highlights the variety of pitfalls and unforeseen complications ranging from recognizing the importance of accurately assessing EPR-related patient risks to understanding the difficulties in the exchange of information across a gradient of distinct interfaces. Furthermore, the tenuous relationship between HIT implementation and patient outcomes in the short-term draws into question the value of EPR construction costs along with the ethical and privacy issues they create. Nonetheless, experts agree that with future software advances and physician familiarization, a robust HIT will be an important asset to patient autonomy, epidemiologic and clinical research, evidence-based error reduction and the potential for cost reduction. This article seeks to review the current status of this initiative and potential pitfalls that remain.

Source